Indian drugmaker Sun Pharma says Halol plant has gained U.S. clearance

MUMBAI (Reuters) - Supply restrictions imposed on India's largest drugmaker Sun Pharmaceutical Industries by U.S. regulators have been lifted, the company said on Tuesday, removing a major drag on its share price.